Literature DB >> 10217027

Decision-making process in patients before entering phase III cancer clinical trials: a pilot study.

G A Huizinga1, D T Sleijfer, H B van de Wiel, W T van der Graaf.   

Abstract

The present study was performed to gain insight into the decision-making process that patients go through when asked to participate in a cancer clinical trial. Fourteen cancer patients entered a pilot study concerning decision making. They were interviewed in a semistructured manner after consenting or refusing to participate in a randomized phase III clinical trial concerning chemotherapy or immunotherapy. Results from this study showed that patients, after receiving information from the medical oncologist, oncology nurse, or both, decide about participation instantaneously. This means that time for procedural soundness has not been used, which raises questions about the normative quality of the decision.

Entities:  

Keywords:  Biomedical and Behavioral Research; Empirical Approach

Mesh:

Year:  1999        PMID: 10217027     DOI: 10.1097/00002820-199904000-00003

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  4 in total

1.  The evaluation of the risks and benefits of phase II cancer clinical trials by institutional review board (IRB) members: a case study.

Authors:  H E M van Luijn; N K Aaronson; R B Keus; A W Musschenga
Journal:  J Med Ethics       Date:  2006-03       Impact factor: 2.903

Review 2.  Cancer patient decision making related to clinical trial participation: an integrative review with implications for patients' relational autonomy.

Authors:  Jennifer A H Bell; Lynda G Balneaves
Journal:  Support Care Cancer       Date:  2015-01-17       Impact factor: 3.603

Review 3.  Deciding to Enrol in a Cancer Trial: A Systematic Review of Qualitative Studies.

Authors:  Bianca Viljoen; Suzanne K Chambers; Jeff Dunn; Nicholas Ralph; Sonja March
Journal:  J Multidiscip Healthc       Date:  2020-10-27

4.  Do cancer patients fully understand clinical trial participation? A pilot study to assess informed consent and patient expectations.

Authors:  Ricardo J Wray; Jo Ellen Stryker; Eric Winer; George Demetri; Karen M Emmons
Journal:  J Cancer Educ       Date:  2007       Impact factor: 2.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.